Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
about
|
my BioMed Central
Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways.
Lu Q, Lin X, Feng J, Zhao X, Gallagher R, Lee MY, Chiao JW, Liu D
J Hematol Oncol
2008,
1
:6
[
Full text
]
[
PubMed
]
[
Related articles
]
[
Cited on BioMed Central
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 1 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
BioMed Central articles that cite the above article:
1.
Review
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
Cang S, Ma Y, Liu D
Journal of Hematology & Oncology
2009,
2
:22
(1 June 2009)
[
Full text
]
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
[
Cited on BioMed Central
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 1 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of
Springer Science+Business Media
.